Clinical Trial Update: Extension Safety and Immunogenicity Study of GPNV-001 [Phase 1, Phase 2]

View source ↗

Summary

Completion of an extension safety and immunogenicity study for the GPNV-001 vaccine candidate in pneumococcal infections (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• GPNV-001 (GPNV-001 vaccine)

Snippet

Sponsor: GPN Vaccines | Conditions: Pneumococcal Infections | Phase 1, Phase 2 | Status: COMPLETED